179 related articles for article (PubMed ID: 23079300)
1. Valuing end-of-life care in the United States: the case of new cancer drugs.
Sorenson C
Health Econ Policy Law; 2012 Oct; 7(4):411-30. PubMed ID: 23079300
[TBL] [Abstract][Full Text] [Related]
2. American Society of Clinical Oncology guidance statement: the cost of cancer care.
Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
[TBL] [Abstract][Full Text] [Related]
3. European perspective on the costs and cost-effectiveness of cancer therapies.
Drummond MF; Mason AR
J Clin Oncol; 2007 Jan; 25(2):191-5. PubMed ID: 17210939
[TBL] [Abstract][Full Text] [Related]
4. Health care costs in end-of-life and palliative care: the quest for ethical reform.
Jennings B; Morrissey MB
J Soc Work End Life Palliat Care; 2011; 7(4):300-17. PubMed ID: 22150176
[TBL] [Abstract][Full Text] [Related]
5. Ethical and value issues in insurance coverage for cancer treatment.
Brock DW
Oncologist; 2010; 15 Suppl 1():36-42. PubMed ID: 20237216
[TBL] [Abstract][Full Text] [Related]
6. Many new cancer drugs in the United Kingdom are facing negative NICE rulings.
Low E;
J Clin Oncol; 2007 Jun; 25(18):2635-6; author reply 2637-8. PubMed ID: 17577049
[No Abstract] [Full Text] [Related]
7. Continental Divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs.
Berry SR; Bell CM; Ubel PA; Evans WK; Nadler E; Strevel EL; Neumann PJ
J Clin Oncol; 2010 Sep; 28(27):4149-53. PubMed ID: 20697077
[TBL] [Abstract][Full Text] [Related]
8. Why managed care should provide supportive therapies for cancer patients.
Rubenstein SA
Manag Care; 1995 Aug; 4(8):37-9. PubMed ID: 10145013
[No Abstract] [Full Text] [Related]
9. Pushback on Zaltrap's price highlights sensitive end-of-life issue.
Dalzell MD
Manag Care; 2012 Dec; 21(12):40-1. PubMed ID: 23304735
[No Abstract] [Full Text] [Related]
10. Drug pricing and value in oncology.
Danzon PM; Taylor E
Oncologist; 2010; 15 Suppl 1():24-31. PubMed ID: 20237214
[TBL] [Abstract][Full Text] [Related]
11. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
[TBL] [Abstract][Full Text] [Related]
12. Cost issues in new disease-modifying treatments for advanced cancer: in-depth interviews with physicians.
de Kort SJ; Kenny N; van Dijk P; Gevers S; Richel DJ; Willems DL
Eur J Cancer; 2007 Sep; 43(13):1983-9. PubMed ID: 17616456
[TBL] [Abstract][Full Text] [Related]
13. The economics of improved cancer survival rates: better outcomes, higher costs.
Uyl-de Groot CA; de Groot S; Steenhoek A
Expert Rev Pharmacoecon Outcomes Res; 2010 Jun; 10(3):283-92. PubMed ID: 20545593
[TBL] [Abstract][Full Text] [Related]
14. Palliative and end-of-life care: policy analysis.
Reb AM
Oncol Nurs Forum; 2003; 30(1):35-50. PubMed ID: 12515982
[TBL] [Abstract][Full Text] [Related]
15. Interpreting the economic literature in oncology.
Grusenmeyer PA; Wong YN
J Clin Oncol; 2007 Jan; 25(2):196-202. PubMed ID: 17210940
[TBL] [Abstract][Full Text] [Related]
16. Innovative cancer therapies: putting costs into context.
Khayat D
Cancer; 2012 May; 118(9):2367-71. PubMed ID: 21918962
[TBL] [Abstract][Full Text] [Related]
17. [Access to cancer care: the cost of treatment matters].
Tirelli U
Recenti Prog Med; 2014 May; 105(5):181-3. PubMed ID: 24873939
[TBL] [Abstract][Full Text] [Related]
18. "It's the economy, stupid": strategies for improved cost containment in cancer treatment.
Sleijfer S
Clin Pharmacol Ther; 2014 Apr; 95(4):365-7. PubMed ID: 24646487
[TBL] [Abstract][Full Text] [Related]
19. [Relevance of pharmacoeconomic analyses to price and reimbursement decisions in Austria].
Führlinger S
Wien Med Wochenschr; 2006 Dec; 156(23-24):612-8. PubMed ID: 17211765
[TBL] [Abstract][Full Text] [Related]
20. [The cost of chemotherapy].
Lévy C; Bonastre J
Bull Cancer; 2003 Nov; 90(11):976-82. PubMed ID: 14706901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
